Vol 35,2026 No.8 | Articles | Chinese Journal of Pharmacoepidemiology

Home Articles Vol 35,2026 No.8

 Contents

Vol 35,2026 No.8

Date of publication: August 15, 2026

 Get cover  Get contents

 Prev
Vol 35,2026 No.7

Analysis of risk factors for acquired drug resistance in new smear-positive pulmonary tuberculosis treated with anti-tuberculosis fixed-dose combination preparations

XU Yingying HE Li

2026,35(8):841-847

Fixed-dose combination tablets Ethambutol pyrazinamide rifampicin and isoniazid tablets Acquired drug resistance Smear-positive pulmonary tuberculosis Drug resistance rate Risk factors
Details Download Mobile
Analysis of distribution characteristics and antimicrobial resistance trends of Gram-negative bacteria in patients with bloodstream infections at a hospital in Yiwu from 2019 to 2024

HUANG Zhouying YU Fanghao HE Jianxin

2026,35(8):848-856

Bloodstream infection Gram-negative bacteria Antimicrobial resistance surveillance Pathogen distribution Change trend Nosocomial infection
Details Download Mobile
Changes in cost characteristics of antibacterial drugs and cardiovascular system drugs in a hospital under the national centralized drug volume-based procurement policy

MI Lili BI Huanglei FU Xinyue HU Xinxin ZHAO Mingfang SU Mengmo ZHANG Jiayue

2026,35(8):857-864

Centralized drug volume-based procurement Cardiovascular system drugs Antibacterial drugs A.M index system Defined daily doses Defined daily cost
Details Download Mobile
Optimizing pharmaceutical care in pediatric intravenous therapy based on perception gaps: a survey of caregivers and healthcare professionals

LIN Jinxiang XU Qianqian ZHANG Qingchi WU Xiuping

2026,35(8):865-872

Pediatrics Perceptions of intravenous therapy Parents Healthcare professionals Rational use of medications
Details Download Mobile
Predictive value of leukocyte-related indicators and IL-6 for the efficacy of cefaclor in the treatment of pneumonia after liver cancer surgery

DING Chenyuan ZHU Feiyan TONG Qingqing

2026,35(8):873-879

Liver cancer Pneumonia Cefaclor Neutrophil to lymphocyte ratio Platelet to lymphocyte ratio Monocyte to lymphocyte ratio Interleukin-6
Details Download Mobile
Mining and analysis of adverse event signals for trofinetide based on FAERS

ZENG Yuanyuan LIU Ling

2026,35(8):880-887

Trofinetide Rett syndrome FAERS database Drug adverse event Signal mining Disproportionality analysis
Details Download Mobile
Real-world study on the safety of benralizumab based on multi-algorithm signal detection

ZHOU Zhou JIANG Linping SHEN Feng

2026,35(8):888-897

Benralizumab FAERS database Real-world study Pharmacovigilance Signal detection
Details Download Mobile
Comparative reporting disproportionality profiles of cardiovascular adverse events associated with JAK inhibitors for rheumatoid arthritis based on FAERS

ZHANG Nana WANG Xiaoyan FANG Zehao JIANG Hongxia YAN Xuefen

2026,35(8):898-906

JAK inhibitors Tofacitinib Baricitinib Upadacitinib Rheumatoid arthritis Cardiovascular adverse events FAERS Comparative reporting odds ratio
Details Download Mobile

Exploration on the application of artificial intelligence and large models in postgraduate education of pharmacology: teaching reform and practical innovation

ZHANG Lele NIU Bei SHENG Feiya

2026,35(8):952-959

Artificial intelligence Pharmacology Postgraduate education Teaching reform Practical innovation
Details Download Mobile

Ischemic bowel disease caused by compound Huangdai tablets: a case report

JIN Hao SONG Yulin YAO Yanxue LI Ting WANG Yanyan

2026,35(8):960-964

Ischemic colitis Compound Huangdai Tablets Adverse drug reaction
Details Download Mobile